Coherus Oncology Inc (CHRS)

Dec 08, 2025

Coherus BioSciences stock jumps after positive cancer drug survival data By Investing.com - Investing.com UK

Dec 08, 2025

Dec 08, 2025

Coherus BioSciences stock jumps after positive cancer drug survival data - Investing.com

Dec 08, 2025

Dec 08, 2025

LOQTORZI plus chemotherapy shows 31-month survival benefit in cancer study - Investing.com

Dec 08, 2025

Dec 08, 2025

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma - The Manila Times

Dec 08, 2025

Dec 06, 2025

Coherus Oncology (CHRS) price target decreased by 11.77% to 5.10 - MSN

Dec 06, 2025

Dec 05, 2025

Why Coherus Oncology Inc. (8C5) stock stays on top picksTrade Risk Summary & Daily Technical Forecast Reports - Newser

Dec 05, 2025

Dec 04, 2025

Why global investors buy Coherus Oncology Inc. (8C5) stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Does Coherus Oncology Inc. (8C5) stock trade below intrinsic valueMarket Volume Summary & Community Consensus Stock Picks - Newser

Dec 04, 2025

Dec 04, 2025

Why Coherus Oncology Inc. (8C5) stock could rally strongly2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - Newser

Dec 04, 2025

Dec 04, 2025

Can Coherus Oncology Inc. (8C5) stock sustain free cash flow2025 Macro Impact & AI Enhanced Trading Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Coherus Oncology, Inc. (NASDAQ:CHRS) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - 富途牛牛

Dec 03, 2025

Dec 03, 2025

Can Coherus Oncology Inc. (8C5) stock hold up in economic slowdownTrade Risk Assessment & Fast Gain Stock Tips - Newser

Dec 03, 2025

Dec 03, 2025

How strong is Coherus Oncology Inc. (8C5) stock earnings growthAnalyst Downgrade & Safe Entry Zone Identification - Newser

Dec 03, 2025

Dec 02, 2025

Coherus Oncology (CHRS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 02, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat

Dec 02, 2025

Nov 30, 2025

Can Coherus Oncology Inc. (8C5) stock survive global slowdown2025 Earnings Surprises & Safe Swing Trade Setups - BỘ NỘI VỤ

Nov 30, 2025

Nov 26, 2025

Is Coherus Oncology Inc 8C5 a good long term investmentEconomic Impact on Stocks & Build Wealth Brick by Brick With Us - earlytimes.in

Nov 26, 2025

Nov 23, 2025

What analysts say about Coherus Oncology Inc 8C5 stockGap Up/Gap Down Analysis & Outstanding Profit Strategies - earlytimes.in

Nov 23, 2025

Nov 23, 2025

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of "Hold" by Brokerages - MarketBeat

Nov 23, 2025

Nov 21, 2025

Will Coherus Oncology Inc. (8C5) stock top growth indexesJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 21, 2025

Nov 21, 2025

Will Coherus Oncology Inc. (8C5) stock outperform value peersPortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Can Coherus Oncology Inc. (8C5) stock attract analyst upgradesJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com

Nov 21, 2025

Nov 20, 2025

Will Coherus Oncology Inc. (8C5) stock benefit from infrastructure billOil Prices & Technical Confirmation Trade Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

How Coherus Oncology Inc. (8C5) stock reacts to Fed tighteningWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Is Coherus Oncology Inc. (8C5) stock included in top ETFs2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025

Nov 19, 2025

Can Coherus Oncology Inc. (8C5) stock retain market dominanceWeekly Risk Summary & AI Enhanced Trading Signals - newser.com

Nov 19, 2025